Latest News
-
Tuesday - September 1, 2009
Strengthening cotton-research:
Bayer CropScience and Performance Plants Inc. sign license agreement on drought-tolerant cotton
-
Tuesday - September 1, 2009
Settlement in appeal proceedings in China:
Bayer CropScience defends mefenpyr safener patent
-
Monday - August 31, 2009
First and only insecticidal active ingredient with two-way transport:
Insecticide Movento® granted regulatory approval in Australia
Bayer CropScience plans market launch before year-end
-
Sunday - August 30, 2009
Bayer Committed to Prevention of Arterial Thrombosis:
Bayer Completes Enrollment into Major Phase III Study with Rivaroxaban (ROCKET AF)
ROCKET AF study compares rivaroxaban to warfarin in the prevention of stroke and non-CNS systemic embolism in patients with Atrial Fibrillation / Bayer Schering Pharma supports Thrombosis Research Institute’s launch of GARFIELD – a global patient Registry to evaluate ‘real life’ outcomes in the prevention of stroke in patients with Atrial Fibrillation / Fast Track designation for rivaroxaban development program in the secondary prevention of cardiovascular events in patients with Acute Coronary Syndrome recognizes high unmet medical need.
-
Thursday - August 20, 2009
Strengthening research and development:
Bayer CropScience and Chromatin Inc. launch mini-chromosome technology alliance
-
Thursday - August 20, 2009
Dreamlike comfort
Bayer MaterialScience and Zentia jointly develop a high performance pillow
-
Thursday - August 20, 2009
Nine-year-old Russian girl wins international children’s painting competition:
Children’s pictures challenge climate change
Bayer and UNEP and other partners present prizes at the environment conference in Korea to children from all over the world who painted pictures on the subject of “Climate Change: Our Challenge” / Record participation through increased number of entries from China: 2.4 million paintings submitted from 89 countries / Motto of the next painting competition: Biodiversity
-
Wednesday - August 19, 2009
Trait platform with extensive product pipeline to deliver innovative solutions for farmers:
Bayer CropScience acquires US biotech company Athenix Corp.
-
Wednesday - August 19, 2009
New Levitra® formulation submitted for registration in the EU
First orodispersible tablet for the treatment of erectile dysfunction
-
Friday - August 14, 2009
Strengthening rice collaborations in China:
Bayer CropScience and China National Rice Research Institute sign agreements for rice research and development
-
Wednesday - August 5, 2009
Proton Pump Inhibitor omeprazole available soon without prescription:
New therapeutic option for heartburn
Bayer Consumer Care New Zealand will launch omeprazole under the Losec® brand without prescription / Bayer will market OTC omeprazole based on an exclusive licensing agreement with AstraZeneca
-
Wednesday - July 29, 2009
Interim report for the second quarter of 2009:
Bayer robust in a difficult environment
HealthCare strong – further growth at CropScience – MaterialScience stabilized / Group sales EUR 8,009 million (minus 5.9 percent) / EBITDA before special items EUR 1,765 million (minus 6.9 percent) / EBIT before special items EUR 1,101 million (minus 11.8 percent) / Group net income EUR 532 million (minus 7.3 percent) / Net cash flow EUR 1,399 million (plus 57.4 percent) / Earnings targets for full year 2009 confirmed
-
Wednesday - July 29, 2009
Bundesdruckerei Group introduces new technology for personalizing polycarbonate high-security cards
Tamper-proof – thanks to colored print image inside the card
A development using materials from Bayer MaterialScience AG
-
Friday - July 24, 2009
VisionWorks "CargoPacks 2020"
-
Wednesday - July 22, 2009
Development of new canola seed varieties:
Bayer CropScience opens canola research facility in Canada
-
Wednesday - July 22, 2009
Nexavar® in Combination with Chemotherapy Shown To Extend Progression-Free Survival in Patients with Advanced Breast Cancer
Statistically Significant Results Reported from a Phase II Study Combining Two Oral Cancer Therapies
-
Wednesday - July 22, 2009
Pharmaceutical quality acetonitrile
Bayer Technology Services has developed a purification process for acetonitrile
Conventional product can be purified for 10 to 17 euros per liter ACN.
-
Tuesday - July 21, 2009
Long-term cooperation with leading Australian research institute CSIRO:
Bayer CropScience expands global R&D activities in seeds and traits by setting up new research focus area in cereals
Superior solutions for wheat farmers could be available as early as 2015
-
Thursday - July 16, 2009
Bayer MaterialScience lifts force majeure for TDI in Europe
-
Tuesday - July 14, 2009
New Drug Application for Rivaroxaban in the U.S.:
Update on Status of Rivaroxaban Complete Response Letter From U.S. FDA
Search
Publications
Stockholders' Newsletter
Annual Report
Sustainable Development Report
The Bayer Climate Program
research – The Bayer Scientific Magazine
Publications Overview
Newsletter
EventsFriday, February 26, 2010
Annual Report 2009 / Financial News Conference Full Year 2009
Contact: Günter Forneck
Additional Press Events
Investor Relations Events
Sport Events
BayKomm Events
Download Center - Selection
